Schedule of Roll Forward Derivatve Liability (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
| Balance at December 31, 2025 | $ 2,279,000 | |
| Balance at June 30, 2026 | 23,000 | $ 2,279,000 |
| Derivative Financial Instruments, Liabilities [Member] | ||
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
| Balance at December 31, 2025 | ||
| Initial value as of June 23, 2025 | 56,298,500 | |
| Settlement of Derivative | (56,298,500) | |
| Balance at June 30, 2026 | ||
| X | ||||||||||
- Definition Fair value measurement with unobservable inputs reconciliation recurring basis liability initial No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|